Related references
Note: Only part of the references are listed.Differential Effects on Light Chain Amyloid Formation Depend on Mutations and Type of Glycosaminoglycans
Luis M. Blancas-Mejia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Bovine serum albumin oligomers in the E- and B-forms at low protein concentration and ionic strength
Jeremiah J. Babcock et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Small heat shock protein AgsA: An effective stabilizer of enzyme activities
Toshifumi Tomoyasu et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2013)
The Amyloid State of Proteins in Human Diseases
David Eisenberg et al.
CELL (2012)
Inhibition of Amyloid Formation
Torleif Hard et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Meta-structure correlation in protein space unveils different selection rules for folded and intrinsically disordered proteins
Yandi Naranjo et al.
MOLECULAR BIOSYSTEMS (2012)
Bovine Serum Albumin protofibril-like aggregates formation: Solo but not simple mechanism
Valeria Vetri et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Insights into the Mechanism of Aggregation and Fibril Formation from Bovine Serum Albumin
Mily Bhattacharya et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2011)
Molecular chaperones in protein folding and proteostasis
F. Ulrich Hartl et al.
NATURE (2011)
Role for apoptosis-inducing factor in the physiological death of cerebellar neurons
Sugela Blancas et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Towards a Pharmacophore for Amyloid
Meytal Landau et al.
PLOS BIOLOGY (2011)
Strategies for the Inhibition of Protein Aggregation in Human Diseases
Manuela Bartolini et al.
CHEMBIOCHEM (2010)
Development of Tau Aggregation Inhibitors for Alzheimer's Disease
Bruno Bulic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
On the Mechanism of Nonspecific Inhibitors of Protein Aggregation: Dissecting the Interactions of α-Synuclein with Congo Red and Lacmoid
Christofer Lendel et al.
BIOCHEMISTRY (2009)
Existence of Different Structural Intermediates on the Fibrillation Pathway of Human Serum Albumin
Josue Juarez et al.
BIOPHYSICAL JOURNAL (2009)
The protein meta-structure: a novel concept for chemical and molecular biology
Robert Konrat
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Influence of Electrostatic Interactions on the Fibrillation Process of Human Serum Albumin
Josue Juarez et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Molecular and cellular aspects of protein misfolding and disease
Eszter Herczenik et al.
FASEB JOURNAL (2008)
Fast conventional Fmoc solid-phase peptide synthesis with HCTU
Christina A. Hood et al.
JOURNAL OF PEPTIDE SCIENCE (2008)
Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of τ aggregation and toxicity in vitro and in cells
Marcus Pickhardt et al.
BIOCHEMISTRY (2007)
A primer of amyloid nomenclature
Per Westermark et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2007)
Aggregation and fibrillation of bovine serum albumin
Nikolaj K. Holm et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2007)
N-phenylamine derivatives as aggregation inhibitors in cell models of Tauopathy
A. Pickhardt et al.
CURRENT ALZHEIMER RESEARCH (2007)
Rhodanine-based tau aggregation inhibitors in cell models of tauopathy
Bruno Bulic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
The structural biology of protein aggregation diseases: Fundamental questions and some answers
David Eisenberg et al.
ACCOUNTS OF CHEMICAL RESEARCH (2006)
Progressive disruption of cellular protein folding in models of polyglutamine diseases
T Gidalevitz et al.
SCIENCE (2006)
3D structure of Alzheimer's amyloid-β(1-42) fibrils
T Lührs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Protein structure similarity clustering and natural product structure as guiding principles in drug discovery
MA Koch et al.
DRUG DISCOVERY TODAY (2005)
Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo
FS Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells
M Pickhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Role of quality control pathways in human diseases involving protein misfolding
WJ Welch
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy
R Khurana et al.
BIOPHYSICAL JOURNAL (2003)
Therapeutic strategies for human amyloid diseases
JC Sacchettini et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
The Hs1U ATPase acts as a molecular chaperone in prevention of aggregation of Su1A, an inhibitor of cell division in Escherichia coli
IS Seong et al.
FEBS LETTERS (2000)
Share Paper
